Statins Use and Risk for Brain Metastasis From Lung Cancer

D. LeighUniversity of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA, Department of Family and Community Medicine, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA, Department of Internal Medicine, Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA, Department of Internal Medicine, VA-Nebraska-Western Iowa Healthcare System, Omaha, Nebraska, USA, Department of Internal Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, North Dakota, USA

J. EkenUniversity of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA, Department of Family and Community Medicine, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA, Department of Internal Medicine, Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA, Department of Internal Medicine, VA-Nebraska-Western Iowa Healthcare System, Omaha, Nebraska, USA, Department of Internal Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, North Dakota, USA

JR BealUniversity of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA, Department of Family and Community Medicine, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA, Department of Internal Medicine, Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA, Department of Internal Medicine, VA-Nebraska-Western Iowa Healthcare System, Omaha, Nebraska, USA, Department of Internal Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, North Dakota, USA

AK GantiUniversity of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA, Department of Family and Community Medicine, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA, Department of Internal Medicine, Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA, Department of Internal Medicine, VA-Nebraska-Western Iowa Healthcare System, Omaha, Nebraska, USA, Department of Internal Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, North Dakota, USA

AE SahmounUniversity of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA, Department of Family and Community Medicine, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA, Department of Internal Medicine, Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA, Department of Internal Medicine, VA-Nebraska-Western Iowa Healthcare System, Omaha, Nebraska, USA, Department of Internal Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, North Dakota, USACorrespondence[email protected]

Abstract

Laboratory data suggest an association between statins and risk of brain metastasis (BM) in patients diagnosed with lung cancer. Our retrospective cohort included 252 patients diagnosed with lung cancer and 55 (22%) patients subsequently developed BM. The risk of BM was significantly higher in younger patients (p < .0007). The multivariable Cox model did not show a significant association between statin use and BM from lung cancer (Hazard-Ratio (HR) = 1.20, 95% confidence interval (CI): 0.68–2.13). Future studies should focus on late stage NSCLC and examine the incidence of BM among statin users at the time of death.

Keywords: :

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Statins Use and Risk for Brain Metastasis From Lung Cancer

Information for

Open access

Opportunities

Help and information

Statins Use and Risk for Brain Metastasis From Lung Cancer

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature